Lime Therapeutics
PrivateLast Round
Seed
Apr 8, 2024
Total Funding Raised
$3.2M
Company Overview
Lime Therapeutics operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in April 2024.
Lime Therapeutics is a biotechnology company that develops lipid-targeting therapies for cancer, cardiometabolic diseases, and neurodegenerative disorders using its proprietary LipidSense™ screening platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lime Therapeutics Comparables
Compare Lime Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeoTrail Therapeutics, Inc. | 73% | |
| Fauna Bio | 66% | |
| Mana.bio | 64% |
For institutional investors. Book with your work email.
Lime Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 8, 2024 | ||||
| Seed | Aug 16, 2023 | ||||
| Grant | Mar 8, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lime Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Grant |
| Coho Deeptech | Seed |
| LifeX Ventures | Seed |
| LifeX Ventures | Seed |
| ZAKA VC | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors grew 67% MoM, from 778 to 1.3K.
- May 1, 2025
Monthly visitors increased 5457% MoM, from 14 to 778.
For institutional investors. Book with your work email.
Lime Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lime Therapeutics's valuation, stock price, and market status.
Is Lime Therapeutics a public or private company?
Lime Therapeutics is a private company.
What is the current stock price of Lime Therapeutics?
Lime Therapeutics is a private company, so its shares have no public market price. Caplight tracks Lime Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lime Therapeutics worth (valuation)?
Valuation information for Lime Therapeutics is not publicly available.
Can I buy Lime Therapeutics stock?
Lime Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lime Therapeutics's last funding round?
Lime Therapeutics's most recent funding round was Seed on April 8, 2024.
Who are the main investors in Lime Therapeutics?
Key investors in Lime Therapeutics include ZAKA VC.
Will Lime Therapeutics IPO soon?
No public IPO plans have been announced for Lime Therapeutics.
How can I track Lime Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Lime Therapeutics's shares on secondary markets.